Design, synthesis and antitumour and anti-angiogenesis evaluation of 22 moscatilin derivatives. Issue 12 (15th June 2019)
- Record Type:
- Journal Article
- Title:
- Design, synthesis and antitumour and anti-angiogenesis evaluation of 22 moscatilin derivatives. Issue 12 (15th June 2019)
- Main Title:
- Design, synthesis and antitumour and anti-angiogenesis evaluation of 22 moscatilin derivatives
- Authors:
- Guan, Li
Zhou, Junting
Lin, Qinghua
Zhu, Huilin
Liu, Wenyuan
Liu, Baolin
Zhang, Yanbo
Zhang, Jie
Gao, Jing
Feng, Feng
Qu, Wei - Abstract:
- Graphical abstract: Highlights: Two series of moscatilin derivatives were designed, synthesized and evaluated as anti-tumor and anti-angiogenesis agents. 8Ae can inhibit the viability and induce the apoptosis of HCT116 cells. 8Ae could arrest G2–M cell-cycle by inhibiting α-tubulin expression. Zebrafish bioassay-guided screen showed compound8Ae had better anti-angiogenic activities than positive compound. Abstract: Two series of moscatilin derivatives were designed, synthesized and evaluated as anti-tumor and anti-angiogenesis agents. Most of these compounds showed moderate-to-obvious cytotoxicity against five cancer cell lines (A549, HepG2, MDA-MB-231, MKN-45, HCT116). Among these cell lines, compounds had obvious effects on HCT116. Especially for8Ae, the IC50 was low to 0.25 μM.8Ae can inhibit the viability and induce the apoptosis of HCT116 cells but exhibit no cytotoxic activity in noncancerous NCM460 colon cells.8Ae can also arrest the G2/M cell cycle in HCT116 cells by inhibiting the α-tubulin expression. Zebrafish bioassay-guided screen showed the 22 moscatilin derivatives had potent anti-angiogenic activities and compound8Ae had better activities than positive compound. Molecular docking indicated 8Ae interacted with tubulin at the affinity of −7.2 Kcal/mol. In conclusion, compound8Ae was a potential antitumor and anti-angiogenesis candidate for further development.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 27:Issue 12(2019)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 27:Issue 12(2019)
- Issue Display:
- Volume 27, Issue 12 (2019)
- Year:
- 2019
- Volume:
- 27
- Issue:
- 12
- Issue Sort Value:
- 2019-0027-0012-0000
- Page Start:
- 2657
- Page End:
- 2665
- Publication Date:
- 2019-06-15
- Subjects:
- Antitumor -- Anti-angiogenesis -- Bibenzyl -- Moscatilin derivatives -- Tubulin
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2019.04.027 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10971.xml